Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer. (Q51968519)
Jump to navigation
Jump to search
scientific article published in January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer. |
scientific article published in January 2008 |
Statements
1 reference
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer. (English)
1 reference
Amorette Barber
1 reference
Tong Zhang
1 reference
Charles L Sentman
1 reference
1 January 2008
1 reference
1 reference
180
1 reference
1
1 reference
72-78
1 reference
Identifiers
1 reference